EUVIMEDEUVIMED entdecken
Crossref

Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency

Gustave Adouvi, Felix Nawa, Marco Ballarotto, Lorena Andrea Rüger, Loris Knümann, Till Kasch, Silvia Arifi, Manfred Schubert-Zsilavecz, Sabine Willems iD, Julian A Marschner, Jörg Pabel iD, Daniel Merk iD

Journal of Medicinal Chemistry · 2023

DOI: 10.1021/acs.jmedchem.3c01435 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2023. Verfasst von Gustave Adouvi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt, Germany. Hauptthemen laut MEDLINE: Receptors, Retinoic Acid, Acrylates. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: European Commission, Deutsche Forschungsgemeinschaft, Friedrich Naumann Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The retinoid X receptors (RXRs) are ligand-activated transcription factors involved in, for example, differentiation and apoptosis regulation. Currently used reference RXR agonists suffer from insufficient specificity and poor physicochemical properties, and improved tools are needed to capture the unexplored therapeutic potential of RXR. Endogenous vitamin A-derived RXR ligands and the natural product RXR agonist valerenic acid comprise acrylic acid residues with varying substitution patterns to engage the critical ionic contact with the binding site arginine. To mimic and exploit this natural ligand motif, we probed its structural fusion with synthetic RXR modulator scaffolds, which had profound effects on agonist activity and remarkably boosted potency of an oxaprozin-derived RXR agonist chemotype. Bioisosteric replacement of the acrylic acid to overcome its pan-assay interference compounds (PAINS) character enabled the development of a highly optimized RXR agonist chemical probe.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Retinoic AcidAcrylatesLigandsRetinoid X Receptors

Substanzen

Receptors, Retinoic Acidacrylic acidLigandsAcrylatesRetinoid X Receptors

Autor:innen und Institutionen

  • Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt, Germany.
  • Department of Pharmacy, Ludwig-Maximilians-Universität München, 81377 Munich, Germany.

ORCID-Profile: Sabine Willems, Jörg Pabel, Daniel Merk

Förderung

  • European Commission
  • Deutsche Forschungsgemeinschaft
  • Friedrich Naumann Stiftung

Zitieren

APA

Adouvi, G., Nawa, F., Ballarotto, M., Rüger, L. A., Knümann, L., Kasch, T., Arifi, S., Schubert-Zsilavecz, M., Willems, S., Marschner, J. A., Pabel, J., & Merk, D. (2023). Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.3c01435

Vancouver

Adouvi G, Nawa F, Ballarotto M, Rüger LA, Knümann L, Kasch T, et al. Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency. Journal of Medicinal Chemistry. 2023. doi:10.1021/acs.jmedchem.3c01435

BibTeX
@article{Adouvi2023,
  author = {Adouvi, Gustave and Nawa, Felix and Ballarotto, Marco and Rüger, Lorena Andrea and Knümann, Loris and Kasch, Till and Arifi, Silvia and Schubert-Zsilavecz, Manfred and Willems, Sabine and Marschner, Julian A and Pabel, Jörg and Merk, Daniel},
  title = {Structural Fusion of Natural and Synthetic Ligand Features Boosts RXR Agonist Potency},
  journal = {Journal of Medicinal Chemistry},
  year = {2023},
  doi = {10.1021/acs.jmedchem.3c01435}
}
Kostenlos starten →